Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics-Reference-Cited by-同舟云学术

Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics

Published:2019-01 Issue:1 Volume:61 Page:87-95
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatrics International

Author:

Shimizu Toshiaki¹^ORCID,Nakayama Yoshiko²^ORCID,Ishii Eizaburo³,Ida Shinobu⁴,Satou Tomoki⁵,Tokuhara Daisuke⁶^ORCID,Arai Katsuhiro⁷,Nii Masahiro⁸,Rydholm Hans⁹,Yajima Toshitaka⁸,

Affiliation:

1. Department of Pediatrics and Adolescent Medicine; Juntendo University Graduate School of Medicine; Matsumoto Nagano Japan

2. Department of Pediatrics; Shinshu University School of Medicine; Matsumoto Nagano Japan

3. Department of Pediatrics; Nagano Prefectural Suzaka Hospital; Suzaka Nagano Japan

4. Department of Pediatric Gastroenterology; Nutrition and Endocrinology, Osaka Women's and Children's Hospital; Izumi Japan

5. Department of Pediatrics; Hiroshima City Funairi Citizens Hospital; Hiroshima Japan

6. Department of Pediatrics; Osaka City University Graduate School of Medicine; Abeno Tokyo Japan

7. Division of Gastroenterology; National Center for Child Health and Development; Setagaya Tokyo Japan

8. Research and Development; AstraZeneca; Kitaku Osaka Japan

9. Global Medicine Development; AstraZeneca Gothenburg; Mölndal Sweden

Funder

AstraZeneca

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ped.13733/fullpdf

Reference23 articles.

1. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus;Vakil;Am. J. Gastroenterol.,2006

2. World Gastroenterology Organisation World Gastroenterology Organisation Global Guidelines: GERD. Global Perspective on Gastroesophageal Reflux Disease 2015 http://www.worldgastroenterology.org/UserFiles/file/guidelines/gastroesophagel-reflux-disease-english-2015.pdf

3. Prevalence of symptoms of gastroesophageal reflux during childhood: A pediatric practice-based survey. Pediatric Practice Research Group;Nelson;Arch. Pediatr. Adolesc. Med.,2000

4. Prevalence of gastroesophageal reflux disease in children, adults, and elderly in the same community;Okimoto;J. Gastroenterol. Hepatol.,2015

5. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population;Sherman;Am. J. Gastroenterol.,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer;European Journal of Pharmaceutical Sciences;2024-07

2. Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease;Pediatric Gastroenterology, Hepatology & Nutrition;2024

3. Gastroesophageal Reflux;Textbook of Pediatric Gastroenterology, Hepatology and Nutrition;2021-11-25

4. Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data;Expert Opinion on Drug Safety;2021-09-20

5. Proton pump inhibitors: Oral treatment of pediatric disorders;Pediatrics International;2019-01